95 related articles for article (PubMed ID: 1599643)
1. The pharmacokinetics and pharmacodynamics of immunosuppressive agents.
Lake KD; Kilkenny JM
Crit Care Nurs Clin North Am; 1992 Jun; 4(2):205-21. PubMed ID: 1599643
[TBL] [Abstract][Full Text] [Related]
2. Nursing implications of immunosuppression in transplantation.
Shaefer M; Williams L
Nurs Clin North Am; 1991 Jun; 26(2):291-314. PubMed ID: 1904575
[TBL] [Abstract][Full Text] [Related]
3. Comparison of cyclosporin A and G with and without azathioprine regarding immunosuppressive efficacy, toxicity, and pharmacokinetics in Lewis rats.
Hagberg RC; Hoyt EG; Billingham ME; Sibley RK; Starnes VA; Baldwin JC
J Heart Transplant; 1988; 7(5):359-69. PubMed ID: 3058906
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the long-term tolerability, pharmacodynamics, and safety of Sandimmune and Neoral in liver transplant recipients. Ontario Liver Transplant Study Group.
Grant D; Rochon J; Levy G
Transplant Proc; 1996 Aug; 28(4):2232-3. PubMed ID: 8769208
[No Abstract] [Full Text] [Related]
5. [Immunosuppressive therapy].
Nakamura H
Rinsho Byori; 1991 Jul; Suppl 90():102-14. PubMed ID: 1920848
[No Abstract] [Full Text] [Related]
6. Complications of immunosuppressive therapy in transplantation. 2: Specific immunosuppressive agents.
Russ GR
Med J Aust; 1992 Aug; 157(4):264-7. PubMed ID: 1435444
[No Abstract] [Full Text] [Related]
7. Pharmacodynamic monitoring of the immunosuppressive therapy in patients after heart transplantation: whole blood flow cytometric analysis of lymphocyte function.
Barten MJ; Rahmel A; Boldt A; Dhein S; Bittner HB; Tarnok A; Mohr FW; Gummert JF
Comput Biol Med; 2007 Oct; 37(10):1367-73. PubMed ID: 17182025
[TBL] [Abstract][Full Text] [Related]
8. [What is meant with immunosuppression?].
Hammer C
Krankenpfl J; 1985; 23(7-8):11-5. PubMed ID: 3850219
[No Abstract] [Full Text] [Related]
9. [Current status of immunosuppression].
Kaspar F
Dtsch Med J; 1968 Apr; 19(7):211-3. PubMed ID: 4180292
[No Abstract] [Full Text] [Related]
10. OKT3 therapy increases cyclosporine blood levels.
Vasquez EM; Pollak R
Clin Transplant; 1997 Feb; 11(1):38-41. PubMed ID: 9067693
[TBL] [Abstract][Full Text] [Related]
11. Prevention and management of the adverse effects associated with immunosuppressive therapy.
Rossi SJ; Schroeder TJ; Hariharan S; First MR
Drug Saf; 1993 Aug; 9(2):104-31. PubMed ID: 8397889
[TBL] [Abstract][Full Text] [Related]
12. Pharmacology of calcineurin antagonists.
Kapturczak MH; Meier-Kriesche HU; Kaplan B
Transplant Proc; 2004 Mar; 36(2 Suppl):25S-32S. PubMed ID: 15041303
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic and pharmacodynamic correlations of cyclosporine therapy in stable renal transplant patients: evaluation of long-term target C(2).
Brunet M; Campistol JM; Millán O; Vidal E; Esforzado N; Rojo I; Jiménez O; Oppenheimer F; Corbella J; Martorell J
Int Immunopharmacol; 2003 Jul; 3(7):987-99. PubMed ID: 12810356
[TBL] [Abstract][Full Text] [Related]
14. Statins' dosage in patients with renal failure and cyclosporine drug-drug interactions in transplant recipient patients.
Launay-Vacher V; Izzedine H; Deray G
Int J Cardiol; 2005 May; 101(1):9-17. PubMed ID: 15860377
[TBL] [Abstract][Full Text] [Related]
15. Immunosuppressive drug use in pregnancy.
Petri M
Autoimmunity; 2003 Feb; 36(1):51-6. PubMed ID: 12765471
[TBL] [Abstract][Full Text] [Related]
16. Complications associated with immunosuppressive therapy and their management.
Min DI; Monaco AP
Pharmacotherapy; 1991; 11(5):119S-125S. PubMed ID: 1745617
[TBL] [Abstract][Full Text] [Related]
17. Complications of immunosuppression.
Penn I
Minerva Chir; 1971 Jul; 26(13):718-20. PubMed ID: 5567243
[No Abstract] [Full Text] [Related]
18. [Molecular mechanisms of action of some immunosuppressive drugs].
Liberman AC; Druker J; Refojo D; Arzt E
Medicina (B Aires); 2008; 68(6):455-64. PubMed ID: 19147430
[TBL] [Abstract][Full Text] [Related]
19. Immunosuppressive agents in dermatology.
Ho VC; Zloty DM
Dermatol Clin; 1993 Jan; 11(1):73-85. PubMed ID: 8435920
[TBL] [Abstract][Full Text] [Related]
20. Anti-CD3 monoclonal antibody induction therapy. Immunological equivalency with triple-drug therapy in heart transplantation.
Barr ML; Sanchez JA; Seche LA; Schulman LL; Smith CR; Rose EA
Circulation; 1990 Nov; 82(5 Suppl):IV291-4. PubMed ID: 2121387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
